Crinetics Pharmaceuticals, Inc.: cashflow_financing
| Value | {"amount": 388944000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | superseded |
| Entity | Crinetics Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:04:12.218403+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/05edff30-4288-45b3-86f7-b0cb11958108
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-24-022108Retrieved: 2026-08-19T17:04:12.218403+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001658247/cashflow-financing/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/05edff30-4288-45b3-86f7-b0cb11958108
History
- no predecessors — first report